TScan Therapeutics (NasdaqGM:TCRX) FY Conference Transcript

TScan Therapeutics (NasdaqGM:TCRX) FY Conference September 10, 2025 09:00 AM ET Company ParticipantsGavin MacBeath - CEOOperatorGreat. Thank you very much, thank you very much for joining the conference. My name is Li Chun and I'm a Quarterly Research Associate with DuckTao. Our next presenting company is TScan Therapeutics. With us today is Mr. Gavin MacBeath, CEO of TScan. It's a clinical stage biotech company focused on the development of TCRT cell therapies for cancer treatment. Please go ahead.Gavin Ma ...